Details for New Drug Application (NDA): 019837
✉ Email this page to a colleague
NDA 019837 describes BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER, which is a drug marketed by B Braun, Baxter Hlthcare, and Hospira Inc, and is included in three NDAs. Additional details are available on the BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER profile page.
The generic ingredient in BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER is bretylium tosylate. There are three drug master file entries for this compound. Additional details are available on the bretylium tosylate profile page.
The generic ingredient in BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER is bretylium tosylate. There are three drug master file entries for this compound. Additional details are available on the bretylium tosylate profile page.
Summary for 019837
| Tradename: | BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER |
| Applicant: | Baxter Hlthcare |
| Ingredient: | bretylium tosylate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 019837
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 400MG/100ML | ||||
| Approval Date: | Apr 12, 1989 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 200MG/100ML | ||||
| Approval Date: | Apr 12, 1989 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
